Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Microsurgery|March 19, 2010
Targeting murine small bowel and colon through selective superior mesenteric artery injectionStacy L Porvasnik, Cathryn Mah, Steven Polyak
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2006
Sustained FVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposonLi Liu, Cathryn Mah, Bradley S Fletcher
Clinical Pharmacokinetics|September 12, 2002
Virus-based gene delivery systemsCathryn Mah, Barry J Byrne, Terence R Flotte
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2004
A new method for recombinant adeno-associated virus vector delivery to murine diaphragmCathryn Mah, Thomas J Fraites, Kerry O Cresawn, et al.
Human Gene Therapy|March 5, 2003
Dual vectors expressing murine factor VIII result in sustained correction of hemophilia A miceCathryn Mah, Rita Sarkar, Irene Zolotukhin, et al.
Digestive Diseases and Sciences|October 16, 2007
Gene delivery to intestinal epithelial cells in vitro and in vivo with recombinant adeno-associated virus types 1, 2 and 5Steven Polyak, Cathryn Mah, Stacy Porvasnik, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 4, 2002
Improved method of recombinant AAV2 delivery for systemic targeted gene therapyCathryn Mah, Thomas J Fraites, Irene Zolotukhin, et al.
Human Gene Therapy|February 11, 2005
Impact of humoral immune response on distribution and efficacy of recombinant adeno-associated virus-derived acid alpha-glucosidase in a model of glycogen storage disease type IIKerry O Cresawn, Thomas J Fraites, Clive Wasserfall, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2009
Neural deficits contribute to respiratory insufficiency in Pompe diseaseLara R DeRuisseau, David D Fuller, Kai Qiu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 25, 2007
Physiological correction of Pompe disease by systemic delivery of adeno-associated virus serotype 1 vectorsCathryn Mah, Christina A Pacak, Kerry O Cresawn, et al.
Pageof 2